You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GCM

Showing 1 - 25 of 127
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Zika Virus Trial in Puerto Rico, United States (mRNA-1893, Placebo)

Active, not recruiting
  • Zika Virus
  • mRNA-1893
  • Placebo
  • Sioux City, Iowa
  • +10 more
Aug 31, 2022

Quality of Life, Burden, Dependency Trial (Activation of a closed loop device in an insulin pump device with GCM)

Not yet recruiting
  • Quality of Life
  • Burden, Dependency
  • Activation of a closed loop device in an insulin pump device with GCM
  • (no location specified)
Jun 24, 2021

Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Scottsdale, Arizona
  • +27 more
May 10, 2022

Autism Spectrum Disorder Trial in Puerto Rico, United States (Cariprazine, Placebo)

Recruiting
  • Autism Spectrum Disorder
  • Anaheim, California
  • +24 more
Aug 11, 2022

Dermatitis, Atopic Trial in Puerto Rico, United States (LY3454738, Placebo)

Completed
  • Dermatitis, Atopic
  • Anniston, Alabama
  • +20 more
Oct 5, 2021

Glomerulosclerosis, Focal Segmental Trial in Worldwide (VX-147)

Completed
  • Glomerulosclerosis, Focal Segmental
  • Birmingham, Alabama
  • +43 more
Nov 10, 2022

Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD) Trial in Puerto Rico, United States (Cariprazine Flexible

Recruiting
  • Schizophrenia
  • +2 more
  • Cariprazine Flexible Dose
  • Dothan, Alabama
  • +32 more
Aug 8, 2022

Systemic Lupus Erythematosus Trial in Worldwide (LY3361237, Placebo)

Recruiting
  • Systemic Lupus Erythematosus
  • Mesa, Arizona
  • +49 more
Jan 17, 2023

Psoriasis Trial in Worldwide (Apremilast, Placebo)

Completed
Has Results
  • Psoriasis
  • Birmingham, Alabama
  • +51 more
Nov 17, 2022

Cognitive Bias and Heuristics in Knee Osteoarthritis

Enrolling by invitation
  • Knee Osteoarthritis
  • Saline
  • Copenhagen, Denmark
    Bispebjerg-Frederiksberg Hospital
Jun 1, 2023

Diabetes, Obesity Trial in Worldwide (PF-07081532, Placebo, Rybelsus)

Recruiting
  • Diabetes Mellitus
  • Obesity
  • Centreville, Alabama
  • +55 more
Jan 18, 2023

Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Sheffield, Alabama
  • +63 more
Oct 6, 2022

Depression, Bipolar I Disorder Trial in Worldwide (Cariprazine, Placebo)

Recruiting
  • Depression
  • Bipolar I Disorder
  • Bentonville, Arkansas
  • +51 more
Aug 22, 2022

Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-3373, Placebo for ABBV-3373, Adalimumab)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +29 more
Jun 29, 2021

Breast Cancer, Cancer Trial in Worldwide (Venetoclax, Capecitabine)

Terminated
  • Breast Cancer
  • Cancer
  • Joliet, Illinois
  • +17 more
Oct 28, 2020

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Placebo)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Huntington Park, California
  • +52 more
Oct 18, 2021

Atopic Dermatitis Trial in Canada, Puerto Rico, United States (Baricitinib)

Completed
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +73 more
Jul 22, 2022

Prevalence of Hyperandrogenism in Type 1 Diabetes

Recruiting
  • Type 1 Diabetes
  • +5 more
  • Clinical hyperandrogenism assessment
  • +20 more
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Mar 14, 2022

Psoriasis Trial in Worldwide (Risankizumab, Placebo for Risankizumab)

Active, not recruiting
  • Psoriasis
  • Glendale, Arizona
  • +54 more
Mar 2, 2022

Neonatal Hypoglycemia Trial in Hershey (Continuous Glucose Monitoring Device)

Recruiting
  • Neonatal Hypoglycemia
  • Continuous Glucose Monitoring Device
  • Hershey, Pennsylvania
    Penn State Health Milton S Hershey Medical Center
Jun 1, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Diabetes, Type 2 Trial in Worldwide (BI 456906, Placebo, Semaglutide)

Completed
  • Diabetes Mellitus, Type 2
  • BI 456906
  • +2 more
  • Huntington Park, California
  • +79 more
Mar 22, 2022

N-terminal Pro-B-type Natriuretic Peptide in Type 2 Diabetes

Recruiting
  • Type2diabetes
  • +2 more
    • Singapore, Singapore
      Singapore General Hospital
    Feb 22, 2023

    Type 2 Diabetes Trial in Mexico, Puerto Rico, United States (LY3209590, Insulin Degludec)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • Birmingham, Alabama
    • +43 more
    Feb 12, 2021

    Episodic Migraine Trial in Worldwide (Atogepant, Placebo-Matching Atogepant)

    Not yet recruiting
    • Episodic Migraine
    • Huntsville, Alabama
    • +89 more
    Jan 26, 2023